A Meta-Analysis of Fecal Bacterial Diversity in Dogs 메타분석을 통한 반려견 분변 박테리아 군집 조사
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Transcriptional Regulation of the Equol Biosynthesis Gene Cluster in Adlercreutzia Equolifaciens DSM19450T
Article Transcriptional Regulation of the Equol Biosynthesis Gene Cluster in Adlercreutzia equolifaciens DSM19450T Ana Belén Flórez 1,*, Lucía Vázquez 1, Javier Rodríguez 1, Begoña Redruello 2 and Baltasar Mayo 1 1 Departamento de Microbiología y Bioquímica, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Paseo Río Linares s/n, Villaviciosa, 33300 Asturias, Spain; [email protected] (L.V.); [email protected] (J.R.); [email protected] (B.M.) 2 Servicios Científico-Técnicos, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Paseo Río Linares s/n, Villaviciosa, 33300 Asturias, Spain; [email protected] * Correspondence: [email protected]; Tel.: +34-985-89-21-31 Received: 25 February 2019; Accepted: 30 April 2019; Published: 30 April 2019 Abstract: Given the emerging evidence of equol’s benefit to human health, understanding its synthesis and regulation in equol-producing bacteria is of paramount importance. Adlercreutzia equolifaciens DSM19450T is a human intestinal bacterium —for which the whole genome sequence is publicly available— that produces equol from the daidzein isoflavone. In the present work, daidzein (between 50 to 200 μM) was completely metabolized by cultures of A. equolifaciens DSM19450T after 10 h of incubation. However, only about one third of the added isoflavone was transformed into dihydrodaidzein and then into equol. Transcriptional analysis of the ORFs and intergenic regions of the bacterium’s equol gene cluster was therefore undertaken using RT-PCR and RT-qPCR techniques with the aim of identifying the genetic elements of equol biosynthesis and its regulation mechanisms. Compared to controls cultured without daidzein, the expression of all 13 contiguous genes in the equol cluster was enhanced in the presence of the isoflavone. -
Senegalemassilia Anaerobia Gen. Nov., Sp. Nov
Standards in Genomic Sciences (2013) 7:343-356 DOI:10.4056/sigs.3246665 Non contiguous-finished genome sequence and description of Senegalemassilia anaerobia gen. nov., sp. nov. Jean-Christophe Lagier1, Khalid Elkarkouri1, Romain Rivet1, Carine Couderc1, Didier Raoult1 and Pierre-Edouard Fournier1* 1 Aix-Marseille Université, URMITE, Faculté de médecine, Marseille, France *Corresponding author: Pierre-Edouard Fournier ([email protected]) Keywords: Senegalemassilia anaerobia, genome Senegalemassilia anaerobia strain JC110T sp.nov. is the type strain of Senegalemassilia anaer- obia gen. nov., sp. nov., the type species of a new genus within the Coriobacteriaceae family, Senegalemassilia gen. nov. This strain, whose genome is described here, was isolated from the fecal flora of a healthy Senegalese patient. S. anaerobia is a Gram-positive anaerobic coccobacillus. Here we describe the features of this organism, together with the complete genome sequence and annotation. The 2,383,131 bp long genome contains 1,932 protein- coding and 58 RNA genes. Introduction Classification and features Senegalemassilia anaerobia strain JC110T (= CSUR A stool sample was collected from a healthy 16- P147 = DSMZ 25959) is the type strain of S. anaer- year-old male Senegalese volunteer patient living obia gen. nov., sp. nov. This bacterium was isolat- in Dielmo (rural village in the Guinean-Sudanian ed from the feces of a healthy Senegalese patient. zone in Senegal), who was included in a research It is a Gram-positive, anaerobic, indole-negative protocol. Written assent was obtained from this coccobacillus. Classically, the polyphasic taxono- individual. No written consent was needed from his my is used to classify the prokaryotes by associat- guardians for this study because he was older than ing phenotypic and genotypic characteristics [1]. -
Daidzein Intake Is Associated with Equol Producing Status Through an Increase in the Intestinal Bacteria Responsible for Equol Production
Article Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production Chikara Iino 1, Tadashi Shimoyama 2,*, Kaori Iino 3, Yoshihito Yokoyama 3, Daisuke Chinda 1, Hirotake Sakuraba 1, Shinsaku Fukuda 1 and Shigeyuki Nakaji 4 1 Department of Gastroenterology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan; [email protected] (C.I.); [email protected] (D.C.); [email protected] (H.S.); [email protected] (S.F.) 2 Aomori General Health Examination Center, Aomori 030-0962, Japan 3 Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan; [email protected] (K.I.); [email protected] (Y.Y.) 4 Department of Social Medicine, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-017-741-2336 Received: 9 January 2019; Accepted: 7 February 2019; Published: 19 February 2019 Abstracts: Equol is a metabolite of isoflavone daidzein and has an affinity to estrogen receptors. Although equol is produced by intestinal bacteria, the association between the status of equol production and the gut microbiota has not been fully investigated. The aim of this study was to compare the intestinal bacteria responsible for equol production in gut microbiota between equol producer and non-producer subjects regarding the intake of daidzein. A total of 1044 adult subjects who participated in a health survey in Hirosaki city were examined. The concentration of equol in urine was measured by high-performance liquid chromatography. -
WO 2018/064165 A2 (.Pdf)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. -
Bacterial Diversity and Functional Analysis of Severe Early Childhood
www.nature.com/scientificreports OPEN Bacterial diversity and functional analysis of severe early childhood caries and recurrence in India Balakrishnan Kalpana1,3, Puniethaa Prabhu3, Ashaq Hussain Bhat3, Arunsaikiran Senthilkumar3, Raj Pranap Arun1, Sharath Asokan4, Sachin S. Gunthe2 & Rama S. Verma1,5* Dental caries is the most prevalent oral disease afecting nearly 70% of children in India and elsewhere. Micro-ecological niche based acidifcation due to dysbiosis in oral microbiome are crucial for caries onset and progression. Here we report the tooth bacteriome diversity compared in Indian children with caries free (CF), severe early childhood caries (SC) and recurrent caries (RC). High quality V3–V4 amplicon sequencing revealed that SC exhibited high bacterial diversity with unique combination and interrelationship. Gracillibacteria_GN02 and TM7 were unique in CF and SC respectively, while Bacteroidetes, Fusobacteria were signifcantly high in RC. Interestingly, we found Streptococcus oralis subsp. tigurinus clade 071 in all groups with signifcant abundance in SC and RC. Positive correlation between low and high abundant bacteria as well as with TCS, PTS and ABC transporters were seen from co-occurrence network analysis. This could lead to persistence of SC niche resulting in RC. Comparative in vitro assessment of bioflm formation showed that the standard culture of S. oralis and its phylogenetically similar clinical isolates showed profound bioflm formation and augmented the growth and enhanced bioflm formation in S. mutans in both dual and multispecies cultures. Interaction among more than 700 species of microbiota under diferent micro-ecological niches of the human oral cavity1,2 acts as a primary defense against various pathogens. Tis has been observed to play a signifcant role in child’s oral and general health. -
Et Al., 2015; Mandell and Green, 2011)
Analysis of the Gut Microbiota of Japanese Alzheimer’s Disease Patients and Characterization of Their Butyrate-Producing Bacteria 2018, July NGUYEN THI THUY TIEN Graduate School of Environmental and Life Science (Doctor’s Course) OKAYAMA UNIVERSITY 0 I. GENERAL INTRODUCTION 1. Overview of Alzheimer’s disease a. Description/Definition Alzheimer’s disease (AD) is the most common type of age-related disease (aged over 65 years old), accounting for about 55 – 70% of dementia (Bertram, 2007; Bu et al., 2015; Mandell and Green, 2011). AD is characterized by progressive loss of memory and neurodegeneration of the central nervous system, leading to disorder in cognition and behavior of AD patients (Bertram, 2007; Mandell and Green, 2011). The life span of AD patients from onset may last about 10 years but can be as long as 20 years. b. Stages and symptoms of Alzheimer’s disease Stages of AD vary among individual and determination of stages that patients are suffering from is the most importance of AD treatment. The standard approach to classify AD stages relies on a mental status examination, the Mini-Mental State Examination (MMSE) (Folstein et al., 1975; Knopman). AD manifestations can be categorized into three stages with symptoms (López and DeKosky, 2008) presented in Table 1. 1 Table 1. MMSE scores and symptoms of each stage of AD (López and DeKosky, 2008) Stage by MMSE Cognitive Behavioral Neurological scores Mild Cognitive function is Apathy and heavy The neurological exam (score ≥ still in fairly good stresses may occur. cannot detect the changes. 20) condition. In this However, their mood is However, mild stage, IADL of still stable. -
WO 2014/135633 Al 12 September 2014 (12.09.2014) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2014/135633 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12N 9/04 (2006.01) C12P 7/16 (2006.01) kind of national protection available): AE, AG, AL, AM, C12N 9/88 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP2014/054334 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 6 March 2014 (06.03.2014) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (26) Publication Language: English TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 13 158012.8 6 March 2013 (06.03.2013) EP (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicants: CLARIANT PRODUKTE (DEUTSCH- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, LAND) GMBH [DE/DE]; Briiningstrasse 50, 65929 UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, Frankfurt am Main (DE). -
GHODGE-DISSERTATION-2015.Pdf (5.049Mb)
MECHANISTIC CHARACTERIZATION AND FUNCTION DISCOVERY OF PHOSPHOHYDROLASE ENZYMES FROM THE AMIDOHYDROLASE SUPERFAMILY A Dissertation by SWAPNIL VIJAY GHODGE Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Chair of Committee, Frank M. Raushel Committee Members, Tadhg P. Begley David P. Barondeau Margaret E. Glasner Head of Department, François Gabbaϊ May 2015 Major Subject: Chemistry Copyright 2015 Swapnil Vijay Ghodge ABSTRACT Rapid advances in genome sequencing technology have created a wide gap between the number of available protein sequences, and reliable knowledge of their respective physiological functions. This work attempted to bridge this gap within the confines cog1387 and cog0613, from the polymerase and histidinol phosphatase (PHP) family of proteins, which is related to the amidohydrolase superfamily (AHS). The adopted approach involved using the mechanistic knowledge of a known enzymatic reaction, and discovering functions of closely related homologs using various tools including bioinformatics and rational library screening. L-histidinol phosphate phosphatase (HPP) catalyzes the penultimate step in the biosynthesis of the amino acid: L-histidine. Recombinant HPP from L.lactis was purified and its metal content and activity were optimized. Mechanistic and structural studies were conducted using pH-Rate profiles, solvent isotope, viscosity effects, site-directed mutagenesis, and X-ray crystallography. These studies, along with extensive bioinformatic analysis, helped determine the boundaries of HPP activity among closely related enzyme sequences within cog1387. Elen0235 from cog0613 was shown to hydrolyze 5-phosphoribose-1,2- cyclicphosphate (PRcP) to ribose-5-phosphate (R5P) and inorganic phosphate (Pi), with ribose-2,5-bisphosphate as a catalytic intermediate. -
MICRO-ORGANISMS and RUMINANT DIGESTION: STATE of KNOWLEDGE, TRENDS and FUTURE PROSPECTS Chris Mcsweeney1 and Rod Mackie2
BACKGROUND STUDY PAPER NO. 61 September 2012 E Organización Food and Organisation des Продовольственная и cельскохозяйственная de las Agriculture Nations Unies Naciones Unidas Organization pour организация para la of the l'alimentation Объединенных Alimentación y la United Nations et l'agriculture Наций Agricultura COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE MICRO-ORGANISMS AND RUMINANT DIGESTION: STATE OF KNOWLEDGE, TRENDS AND FUTURE PROSPECTS Chris McSweeney1 and Rod Mackie2 The content of this document is entirely the responsibility of the authors, and does not necessarily represent the views of the FAO or its Members. 1 Commonwealth Scientific and Industrial Research Organisation, Livestock Industries, 306 Carmody Road, St Lucia Qld 4067, Australia. 2 University of Illinois, Urbana, Illinois, United States of America. This document is printed in limited numbers to minimize the environmental impact of FAO's processes and contribute to climate neutrality. Delegates and observers are kindly requested to bring their copies to meetings and to avoid asking for additional copies. Most FAO meeting documents are available on the Internet at www.fao.org ME992 BACKGROUND STUDY PAPER NO.61 2 Table of Contents Pages I EXECUTIVE SUMMARY .............................................................................................. 5 II INTRODUCTION ............................................................................................................ 7 Scope of the Study ........................................................................................................... -
Updates on the Sporulation Process in Clostridium Species
Updates on the sporulation process in Clostridium species Talukdar, P. K., Olguín-Araneda, V., Alnoman, M., Paredes-Sabja, D., & Sarker, M. R. (2015). Updates on the sporulation process in Clostridium species. Research in Microbiology, 166(4), 225-235. doi:10.1016/j.resmic.2014.12.001 10.1016/j.resmic.2014.12.001 Elsevier Accepted Manuscript http://cdss.library.oregonstate.edu/sa-termsofuse *Manuscript 1 Review article for publication in special issue: Genetics of toxigenic Clostridia 2 3 Updates on the sporulation process in Clostridium species 4 5 Prabhat K. Talukdar1, 2, Valeria Olguín-Araneda3, Maryam Alnoman1, 2, Daniel Paredes-Sabja1, 3, 6 Mahfuzur R. Sarker1, 2. 7 8 1Department of Biomedical Sciences, College of Veterinary Medicine and 2Department of 9 Microbiology, College of Science, Oregon State University, Corvallis, OR. U.S.A; 3Laboratorio 10 de Mecanismos de Patogénesis Bacteriana, Departamento de Ciencias Biológicas, Facultad de 11 Ciencias Biológicas, Universidad Andrés Bello, Santiago, Chile. 12 13 14 Running Title: Clostridium spore formation. 15 16 17 Key Words: Clostridium, spores, sporulation, Spo0A, sigma factors 18 19 20 Corresponding author: Dr. Mahfuzur Sarker, Department of Biomedical Sciences, College of 21 Veterinary Medicine, Oregon State University, 216 Dryden Hall, Corvallis, OR 97331. Tel: 541- 22 737-6918; Fax: 541-737-2730; e-mail: [email protected] 23 1 24 25 Abstract 26 Sporulation is an important strategy for certain bacterial species within the phylum Firmicutes to 27 survive longer periods of time in adverse conditions. All spore-forming bacteria have two phases 28 in their life; the vegetative form, where they can maintain all metabolic activities and replicate to 29 increase numbers, and the spore form, where no metabolic activities exist. -
Product Sheet Info
Product Information Sheet for HM-1099 Eggerthella sp., Strain MVA1 Tryptic soy agar with 5% defibrinated sheep blood or Modified Chopped Meat agar with 0.5% arginine or equivalent Incubation: Catalog No. HM-1099 Temperature: 37°C Atmosphere: Anaerobic For research use only. Not for human use. Propagation: 1. Keep vial frozen until ready for use, then thaw. Contributor: 2. Transfer the entire thawed aliquot into a single tube of broth. Maria V. Sizova, Department of Biology, Northeastern 3. Use several drops of the suspension to inoculate an agar University, Boston, Massachusetts, USA slant and/or plate. 4. Incubate the tube, slant and/or plate at 37°C for 2 to 4 days. Manufacturer: BEI Resources Citation: Acknowledgment for publications should read “The following Product Description: reagent was obtained through BEI Resources, NIAID, NIH as Bacteria Classification: Eggerthellaceae, Eggerthella part of the Human Microbiome Project: Eggerthella sp., Strain Species: Eggerthella sp. MVA1, HM-1099.” Strain: MVA1 Original Source: Eggerthella sp., strain MVA1 is a vaginal Biosafety Level: 2 isolate obtained in 2011 from a woman with bacterial Appropriate safety procedures should always be used with this vaginosis in Seattle, Washington, USA.1,2 material. Laboratory safety is discussed in the following Comments: Eggerthella sp., strain MVA1 (HMP ID 1636) is a publication: U.S. Department of Health and Human Services, reference genome for The Human Microbiome Project (HMP). Public Health Service, Centers for Disease Control and HMP is an initiative to identify and characterize human Prevention, and National Institutes of Health. Biosafety in microbial flora. The complete genome of Microbiological and Biomedical Laboratories. -
General Introduction
Opgedragen aan Lotte, Yenthe en Seppe This work was supported by grants from the Bijzonder Onderzoeks Fonds (BOF), Ghent University, Belgium; the Fund for Scientific Research (FWO) Flanders, Belgium and the Marie Marguérite Delacroix Fund, Belgium. Faculty of Medicine and Health Sciences Department Clinical Chemistry, Microbiology and Immunology Laboratory Bacteriology Research Characterization of the vaginal microflora Rita Verhelst Promotors: Prof. Dr. Mario Vaneechoutte Prof. Dr. Marleen Temmerman Dissertation submitted in fulfillment of the requirements for the degree of Doctor in Biomedical Sciences, Faculty of Medicine, University of Ghent April 2006 PROMOTORS LEDEN VAN DE EXAMENCOMMISSIE Prof. Dr. Mario Vaneechoutte VOORZITTER Prof. Dr. Geert Leroux-Roels Vakgroep Klinische biologie, microbiologie en immunologie Vakgroep Klinische biologie, microbiologie en immunologie Universiteit Gent Universiteit Gent Prof. Dr. Marleen Temmerman Prof. Dr. Geert Claeys Vakgroep Uro-gynaecologie Vakgroep Klinische biologie, microbiologie en immunologie Universiteit Gent Universiteit Gent Prof. Dr. Denis Pierard Departement Microbiologie Academisch Ziekenhuis Vrije Universiteit Brussel Prof. Dr. Koenraad Smets Vakgroep Pediatrie en genetica Universiteit Gent Prof. Dr. Guido Van Ham Departement Microbiolgie Instituut voor Tropische Geneeskunde, Antwerpen Prof. Dr. Gerda Verschraegen Vakgroep Klinische biologie, microbiologie en immunologie Universiteit Gent Dr. Nico Boon Vakgroep Biochemische en microbiële technologie Universiteit Gent Table of